World Meningococcal Vaccines Market - Opportunities & Forecasts to 2022 - Increasing Incidence of Meningitis Across the World - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "World Meningococcal Vaccines Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.

Meningococcal vaccines are used to treat meningitis caused by bacterium N. meningitidis. Previously there were no precautionary measures available to avoid meningitis. Antibiotics along with nutrient supplements were used to treat this disease after infection was confirmed. However, with the advent of meningococcal vaccine, meningitis could be prevented. The global market for vaccines was estimated to be $24 billion in 2013.

The increasing incidence of meningitis across the world is the major driving force for this market. Rising awareness level of diseases and their vaccines also drives the market for meningococcal vaccines. The maintenance of cold chain for the delivery of vaccines leads to rise in cost of vaccination, which serves as the major limiting factor for this market.

World Health Organization is promoting strategies for prevention of meningitis and is hoping to introduce this vaccine in 26 countries of African region, which are suffering from meningitis and they hope to achieve it by 2016. This would provide growth opportunities in this market.

Scope of the Report:

Market by Types:

  • Quadrivalent vaccines
  • Bivalent vaccines
  • Serogroup A
  • Serogroup B
  • Serogroup X

Market by Geography:

  • North America
  • Europe
  • Asia-pacific
  • RoW

The report analyses global meningococcal vaccines market with the help of Porter's five forces model. Porter's model helps in analyzing the market players, new entrants in the market and the strategies adopted by them. In this market, the unavailability of substitutes result in high bargaining power of suppliers and low bargaining power of buyers. The meningococcal vaccine is a capital-intensive market; therefore, it is difficult for new entrants to enter the business. Market dynamics is analyzed for the benefit of the stakeholders.

For more information about this report visit http://www.researchandmarkets.com/research/fc5tcx/world

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Vaccines